title: In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.
authors.forename: Amanda
authors.initials: A
authors.lastname: Henry
authors.forename: Debra
authors.initials: D
authors.lastname: Kennedy
authors.forename: Sandra
authors.initials: S
authors.lastname: Lowe
mesh_terms: D000322:Adrenergic Agonists / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000139:chemically induced*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*
chemical_list: D000322:Adrenergic Agonists